Clinical Trial Evaluating the Therapeutic Potential of Nelfinavir and Favipiravir Combination in Newly Diagnosed COVID19 Egyptian Patients
Latest Information Update: 17 Jul 2020
At a glance
- Drugs Favipiravir (Primary) ; Nelfinavir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 17 Jul 2021 AS record was not found ,retrieved from cached google link (https://www.google.com/url?q=https://webcache.googleusercontent.com/search?q%3Dcache:SjmvyTT6dFgJ:https://clinicaltrials.gov/ct2/show/NCT04471662%2B%26cd%3D1%26hl%3Den%26ct%3Dclnk%26gl%3Din&sa=D&source=hangouts&ust=1595061104406000&usg=AFQjCNGDOFu6RdL83xlhMhXx6fSQjBGzdA)
- 17 Jul 2020 New trial record